000			02238nam a22004697a 4500
008			210719s20212021 xxu||||| |||| 00| 0 eng d
022			_a0950-222X
024			_a10.1038/s41433-021-01570-6 [doi]
024			_a10.1038/s41433-021-01570-6 [pii]
040			_aOvid MEDLINE(R)
099			_a34117399
245			_aCurrent and novel multi-imaging modalities to assess retinal oxygenation and blood flow. [Review]
251			_aEye. 35(11):2962-2972, 2021 11.
252			_aEye. 35(11):2962-2972, 2021 11.
252			_zEye. 2021 Jun 11
253			_aEye (London, England)
260			_c2021
260			_fFY2022
260			_p2021 Jun 11
265			_saheadofprint
265			_sppublish
266			_d2021-07-19
268			_aEye. 2021 Jun 11
269			_fFY2021
520			_aRetinal ischemia characterizes the underlying pathology in a multitude of retinal diseases that can ultimately lead to vision loss. A variety of novel imaging modalities have been developed to characterize retinal ischemia by measuring retinal oxygenation and blood flow in-vivo. These technologies offer valuable insight into the earliest pathophysiologic changes within the retina and provide physicians and researchers with new diagnostic and monitoring capabilities. Future retinal imaging technologies with the capability to provide affordable, noninvasive, and comprehensive data on oxygen saturation, vasculature, and blood flow mechanics are needed. This review will highlight current and future trends in multimodal imaging to assess retinal blood flow and oxygenation.
546			_aEnglish
650			_a*Oxygen
650			_a*Retinal Diseases
650			_aDiagnostic Imaging
650			_aHumans
650			_aRegional Blood Flow
650			_aRetina/dg [Diagnostic Imaging]
650			_aRetinal Diseases/dg [Diagnostic Imaging]
651			_aMedStar Union Memorial Hospital
656			_aInternal Medicine Residency
657			_aJournal Article
657			_aReview
700			_aMarino, Michael
790			_aGehlbach PL, Jiramongkolchai K, Marino MJ, Rege A
856			_uhttps://dx.doi.org/10.1038/s41433-021-01570-6 _zhttps://dx.doi.org/10.1038/s41433-021-01570-6
942			_cART _dArticle
999			_c6611 _d6611